儿童腺样体肥大与咽喉反流的相关性研究

黄俣栋, 谭嘉杰, 韩晓燕, 等. 儿童腺样体肥大与咽喉反流的相关性研究[J]. 临床耳鼻咽喉头颈外科杂志, 2018, 32(12): 899-904. doi: 10.13201/j.issn.1001-1781.2018.12.005
引用本文: 黄俣栋, 谭嘉杰, 韩晓燕, 等. 儿童腺样体肥大与咽喉反流的相关性研究[J]. 临床耳鼻咽喉头颈外科杂志, 2018, 32(12): 899-904. doi: 10.13201/j.issn.1001-1781.2018.12.005
HUANG Yudong, TAN Jiajie, HAN Xiaoyan, et al. Study on the correlation between adenoid hypertrophy and laryngopharyngeal reflux in children[J]. J Clin Otorhinolaryngol Head Neck Surg, 2018, 32(12): 899-904. doi: 10.13201/j.issn.1001-1781.2018.12.005
Citation: HUANG Yudong, TAN Jiajie, HAN Xiaoyan, et al. Study on the correlation between adenoid hypertrophy and laryngopharyngeal reflux in children[J]. J Clin Otorhinolaryngol Head Neck Surg, 2018, 32(12): 899-904. doi: 10.13201/j.issn.1001-1781.2018.12.005

儿童腺样体肥大与咽喉反流的相关性研究

  • 基金项目:

    国家自然科学基金青年科学基金项目(No:81400452)

详细信息
    通讯作者: 李湘平,E-mail:li321162@qq.com
  • 中图分类号: R766;R767

Study on the correlation between adenoid hypertrophy and laryngopharyngeal reflux in children

More Information
  • 目的:探讨儿童腺样体肥大与咽喉反流的相关性,评估咽喉反流症状指数量表(RSI)及咽喉反流体征量表(RFS)对预测腺样体肥大与咽喉反流相关的准确性。方法:因腺样体肥大行手术治疗的患儿71例,完成RSI及RFS量表评估。留取患儿手术切除的腺样体组织行胃蛋白酶(pepsin)免疫组织化学染色。根据pepsin染色阳性结果,对RSI、RFS量表预测腺样体肥大患儿合并咽喉反流的敏感性与特异性进行评估。结果:71例腺样体肥大患儿中,RSI>13分4例(5.63%),RFS >7分26例(36.62%),两项评分均为阳性1例(1.41%)。在腺样体肥大组织中检测到pepsin表达52例,总阳性率73.24%(52/71),以强阳性(15/71,21.13%)和阳性(23/71,32.39%)为主。腺样体肥大分级越高,pepsin表达强度越高(r=0.476,P<0.01)。以腺样体组织pepsin阳性做为诊断咽喉反流的金标准,RSI及RFS敏感性分别为5.77%、34.62%,特异性分别为94.74%、57.89%。pepsin染色强度与烦人的咳嗽呈正相关(r=0.356,P=0.002),与喉室消失呈负相关(r=-0.212,P=0.038)。结论:儿童腺样体肥大与咽喉反流存在相关性,咽喉反流在腺样体的发展进程中起重要作用。RSI及RFS的敏感性低,不适用于腺样体肥大儿童存在咽喉反流的筛查。当腺样体肥大儿童长期咳嗽且行电子鼻咽喉镜检查发现喉室消失表现时,应警惕存在咽喉反流。
  • 加载中
  • [1]

    MARSEGLIA G L, CAIMMI D, PAGELLA F, et al.Adenoids during childhood:the facts[J].Int J Immunopathol Pharmacol, 2011, 24(4Suppl):1-5.

    [2]

    KELES B, OZTURK K, ARBAG H, et al.Frequency of pharyngeal reflux in children with adenoid hyperplasia[J].Int J Pediatr Otorhinolaryngol, 2005, 69:1103-1107.

    [3]

    MARZOUK H, AYNEHCHI B, THAKKAR P, et al.The utility of nasopharyngeal culture in the management of chronic adenoiditis[J].Int J Pediatr Otorhinolaryngol, 2012, 76:1413-1415.

    [4]

    STAPLETON A, BRODSKY L.Extra-esophageal acid reflux induced adenotonsillar hyperplasia:case report and literature review[J].Int J Pediatr Otorhinolaryngol, 2008, 72:409-413.

    [5]

    CARR M M, POJE C P, EHRIG D, et al.Incidence of reflux in young children undergoing adenoidectomy[J].Laryngoscope, 2001, 111:2170-2172.

    [6]

    STAVROULAKI P.Diagnostic and management problems of laryngopharyngeal reflux disease in children[J].Int J Pediatr Otorhinolaryngol, 2006, 70:579-590.

    [7]

    VENKATESAN N N, PINE H S, UNDERBRINK M.Laryngopharyngeal reflux disease in children[J].Pediatr Clin North Am, 2013, 60:865-878.

    [8]

    WANG L, TAN J J, WU T, et al.Association between Laryngeal Pepsin Levels and the Presence of Vocal Fold Polyps[J].Otolaryngol Head Neck Surg, 2017, 156:144-151.

    [9]

    LUEBKE K, SAMUELS T L, CHELIUS T H, et al.Pepsin as a biomarker for laryngopharyngeal reflux in children with laryngomalacia[J].Laryngoscope, 2017, 127:2413-2417.

    [10]

    王秀, 陈伟, 王秋萍.胃蛋白酶检测在咽喉反流疾病诊断中的应用[J].临床耳鼻咽喉头颈外科杂志, 2017, 31(9):728-731.

    [11]

    CASSANO P, GELARDI M, CASSANO M, et al.Adenoid tissue rhinopharyngeal obstruction grading based on fiberendoscopic findings:a novel approach to therapeutic management[J].Int J Pediatr Otorhinolaryngol, 2003, 67:1303-1309.

    [12]

    BELAFSKY P C, POSTMA G N, KOUFMAN J A.Validity and reliability of the reflux symptom index (RSI)[J].J Voice, 2002, 16:274-277.

    [13]

    BELAFSKY P C, POSTMA G N, KOUFMAN J A.The validity and reliability of the reflux finding score (RFS)[J].Laryngoscope, 2001, 111:1313-1317.

    [14]

    SILLEM M, HAHN U, CODDINGTON C C, et al.Ectopic growth of endometrium depends on its structural integrity and proteolytic activity in the cynomolgus monkey (Macaca fascicularis) model of endometriosis[J].Fertil Steril, 1996, 66:468-473.

    [15]

    KILIC M, OZTURK F, KIRMEMIS O, et al.Impact of laryngopharyngeal and gastroesophageal reflux on asthma control in children[J].Int J Pediatr Otorhinolaryngol, 2013, 77:341-345.

    [16]

    李晓云, 李进让, 张淑君, 等.慢性鼻窦炎与咽喉反流的相关性研究[J].临床耳鼻咽喉头颈外科杂志, 2017, 31(23):1828-1832.

    [17]

    O'REILLY R C, HE Z, BLOEDON E, et al.The role of extraesophageal reflux in otitis media in infants and children[J].Laryngoscope, 2008, 118(7Part 2Suppl116):1-9.

    [18]

    DEARKING A C, LAHR B D, KUCHENA A, et al.Factors associated with revision adenoidectomy[J].Otolaryngol Head Neck Surg, 2012, 146:984-990.

    [19]

    MCCORMICK M E, SHEYN A, HAUPERT M, et al.Gastroesophageal reflux as a predictor of complications after adenotonsillectomy in young children[J].Int J Pediatr Otorhinolaryngol, 2013, 77:1575-1578.

    [20]

    ESKIIZMIR G, KEZIRIAN E.Is there a vicious cycle between obstructive sleep apnea and laryngopharyngeal reflux disease[J]?Med Hypotheses, 2009, 73:706-708.

    [21]

    SHEPHERD K, ORR W.Mechanism of gastroesophageal reflux in obstructive sleep apnea:airway obstruction or obesity[J]?J Clin Sleep Med, 2016, 12:87-94.

    [22]

    KURIBAYASHI S, KUSANO M, KAWAMURA O, et al.Mechanism of gastroesophageal reflux in patients with obstructive sleep apnea syndrome[J].Neurogastroenterol Motil, 2010, 22:611-e172.

    [23]

    KURIBAYASHI S, MASSEY B T, HAFEEZULLAH M, et al.Upper esophageal sphincter and gastroesophageal junction pressure changes act to prevent gastroesophageal and esophagopharyngeal reflux during apneic episodes in patients with obstructive sleep apnea[J].Chest, 2010, 137:769-776.

    [24]

    JOHNSTON N, DETTMAR P W, BISHWOKARMA B, et al.Activity/stability of human pepsin:implications for reflux attributed laryngeal disease[J].Laryngoscope, 2007, 117:1036-1039.

    [25]

    JOHNSTON N, WELLS C W, BLUMIN J H, et al.Receptor-mediated uptake of pepsin by laryngeal epithelial cells[J].Ann Otol Rhinol Laryngol, 2007, 116:934-938.

    [26]

    JOHNSTON N, WELLS C W, SAMUELS T L, et al.Rationale for targeting pepsin in the treatment of reflux disease[J].Ann Otol Rhinol Laryngol, 2010, 119:547-558.

    [27]

    SAMUELS T L, JOHNSTON N.Pepsin as a causal agent of inflammation during nonacidic refluxs[J].Otolaryngol Head Neck Surg, 2009, 141:559-563.

    [28]

    KIM J H, JEONG H S, KIM K M, et al.Extra-Esophageal Pepsin from Stomach Refluxate Promoted Tonsil Hypertrophy[J].PLoS One, 2016, 11:e0152336.

    [29]

    邓月琴, 王路, 陈怀宏, 等.胃蛋白酶在舌扁桃体组织中的表达及临床意义[J].中华耳鼻咽喉头颈外科杂志, 2017, 52(7):525-530.

    [30]

    李湘平, 吴婷, 王路, 等.埃索美拉唑治疗咽喉反流的疗效评估[J].临床耳鼻咽喉头颈外科杂志, 2011, 25(9):388-391.

    [31]

    BOOK D T, RHEE J S, TOOHILL R J.Perspectives in laryngopharyngeal reflux:an international survey[J].Laryngoscope, 2002, 112(8Pt 1):1399-1406.

  • 加载中
计量
  • 文章访问数:  117
  • PDF下载数:  65
  • 施引文献:  0
出版历程
收稿日期:  2018-04-17

目录